Overexpression of Pim‐1 is associated with poor prognosis in patients with esophageal squamous cell carcinoma
Authors:
- 22 October 2010
- journal article
- research article
- Published by Wiley in Journal of Surgical Oncology
- Vol. 102 (6) , 683-688
Abstract
Background and Objectives: It is well known that provirus integration site for Moloney murine leukemia virus 1 (Pim‐1) plays an essential role in the occurrence and development of tumors. Here, we investigated expression of Pim‐1 in esophageal squamous cell carcinoma (ESCC) and assessed the correlation between Pim‐1 level and prognosis of the patients with ESCC.Methods: Expression of Pim‐1 was investigated by RT‐PCR, immunohistochemistry, and in situ hybridization methods. Kaplan–Meier statistics was used to examine the relationship between levels of Pim‐1 and prognosis using log‐rank test.Results: The results demonstrated that ESCC tissues appeared strong expression levels of Pim‐1 mRNA and protein while the normal esophageal tissues were either negative or showed only weak Pim‐1 mRNA and protein levels. In addition, we found that Pim‐1 expression was significantly correlated with histology grade, clinical staging, and lymph node metastasis (all P < 0.05), but not related to age and sex (all P > 0.05). Furthermore, the results of survival rates analyzed by Kaplan–Meier curve revealed that patients with high Pim‐1 mRNA and protein expressions had a poorer prognosis than those with the low Pim‐1 expression (P = 0.010 and 0.001, respectively).Conclusion: These findings demonstrate that Pim‐1 may be used as molecular marker for predicting the prognosis of patients with ESCC. J. Surg. Oncol. 2010;102:683–688.Keywords
This publication has 30 references indexed in Scilit:
- Pim kinase inhibitor, SGI-1776, induces apoptosis in chronic lymphocytic leukemia cellsBlood, 2009
- Hypoxia-Mediated Up-Regulation of Pim-1 Contributes to Solid Tumor FormationThe American Journal of Pathology, 2009
- Pim-1 plays a pivotal role in hypoxia-induced chemoresistanceOncogene, 2009
- The PIM1 Kinase Is a Critical Component of a Survival Pathway Activated by Docetaxel and Promotes Survival of Docetaxel-treated Prostate Cancer CellsJournal of Biological Chemistry, 2008
- Esophageal squamous cell carcinoma presenting with extensive skin lesions: a case reportJournal of Medical Case Reports, 2008
- Kruppel-like factor 5 modulates p53-independent apoptosis through Pim1 survival kinase in cancer cellsOncogene, 2007
- Cancer Statistics, 2005CA: A Cancer Journal for Clinicians, 2005
- Myc-driven murine prostate cancer shares molecular features with human prostate tumorsCancer Cell, 2003
- Myosin XVA Expression in the Pituitary and in Other Neuroendocrine Tissues and TumorsThe American Journal of Pathology, 2001
- High prevalence of p53 protein overexpression in patients with esophageal cancer in Linxian, China and its relationship to progression and prognosisCancer, 1994